Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI
about
Role of type I interferons in the activation of autoreactive B cellsEffect of TACI signaling on humoral immunity and autoimmune diseasesPulmonary infection with influenza A virus induces site-specific germinal center and T follicular helper cell responsesImmune Responses to Influenza Virus and Its Correlation to Age and Inherited FactorsPrimary and long-term B-cell responses in the upper airway and lung after influenza A virus infection.Asthma increases susceptibility to heterologous but not homologous secondary influenzaAPRIL mediates peritoneal B-1 cell homeostasis.Modeling the dynamics and migratory pathways of virus-specific antibody-secreting cell populations in primary influenza infectionPneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced diseaseCoinfection with Streptococcus pneumoniae modulates the B cell response to influenza virusTACI deficiency enhances antibody avidity and clearance of an intestinal pathogenDNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titersTargeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses.TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection.Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE).B cell activating factor inhibition impairs bacterial immunity by reducing T cell-independent IgM secretion.Induction of respiratory immune responses in the chicken; implications for development of mucosal avian influenza virus vaccines.Immune Cell Dynamics in Rhesus Macaques Infected with a Brazilian Strain of Zika Virus.Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus.Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.The Role of BAFF System Molecules in Host Response to Pathogens.The long and winding road to IgA deficiency: causes and consequences.Here, There, and Anywhere? Arguments for and against the Physical Plasma Cell Survival Niche.T Regulatory Cells Support Plasma Cell Populations in the Bone Marrow.Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis.Fas/FasL and perforin-granzyme pathways mediated T cell cytotoxic responses in infectious bursal disease virus infected chickens.Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes.TBK1 suppression of IgA in the NIK of time.
P2860
Q26858821-FFC7434E-7E9B-4BDE-8D31-20C73AC84C3AQ26995571-7AF1E0F2-2CA6-44DD-BF8D-3167FAEEE7E5Q27334210-A1929FB3-4F0A-499D-972F-FA17E765A369Q28075495-B1D7E50A-3423-4283-91AE-7318BDE10975Q30362668-D7B82DEC-AD5D-432F-92B1-C0EDC7B59155Q30363298-93C2248F-5733-4348-8A63-8B0318013F1FQ33758475-3CEFDECC-F035-4D0D-AEFB-3C5A81534360Q34109651-00E83D93-EC52-4328-8CB3-9F2100259301Q34149169-AC0D816E-FD1A-4260-8DAA-743764E7FCADQ34261558-B579BD5E-8CB0-434E-93C8-678FA6EBE032Q35140137-BC1743CC-46A3-4275-838A-60390E755005Q35640984-5AEF9932-93DD-409F-B32C-054D99CE50F8Q35826171-97D35D90-38F7-4C16-9AFD-3B09A71A2B8FQ35910201-CE401783-ADBA-4A82-A9C2-67518E45832BQ36271212-7682A2F4-3752-48D7-84AE-DC6F26A1EE5DQ37336043-138DC989-C133-45D9-86FB-0562CF5F20FFQ38031950-53588123-F9F2-459F-A7D0-BC58B2DCFDCCQ38158274-8AB01C60-588B-44FD-AAD0-1C4264C87298Q38187489-CB0FFBDB-57DB-48C8-B2C1-FC4AAB65D60BQ38269845-75BD16BE-F6AC-4EBD-93FA-C4F481C756A4Q38601694-EA75E3D6-FB58-4C8E-B56F-E9DAE227D27BQ38989513-A457C3E4-8ED3-4F6D-9070-1140B71B56C7Q39455345-16783AD8-8A28-45EF-89A1-4980BACCE133Q40321710-C106858A-F72F-4633-BEC7-9C43815F215AQ40355293-7467EBDC-3A5B-49D0-A569-EBF7F41C3E4FQ42084275-9E9CE008-36DD-44F4-856A-9066BE8791F9Q49808758-74BF79C2-C818-48F1-868F-44E4A2791904Q54476546-86CDC9DE-0D05-4C7D-9839-BB60F91273E3
P2860
Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Protective antiviral antibody ...... a virus infection require TACI
@ast
Protective antiviral antibody ...... a virus infection require TACI
@en
type
label
Protective antiviral antibody ...... a virus infection require TACI
@ast
Protective antiviral antibody ...... a virus infection require TACI
@en
prefLabel
Protective antiviral antibody ...... a virus infection require TACI
@ast
Protective antiviral antibody ...... a virus infection require TACI
@en
P2093
P2860
P356
P1476
Protective antiviral antibody ...... a virus infection require TACI
@en
P2093
Amaya I Wolf
Andrew J Caton
David Allman
Eric Meffre
Jan Erikson
Katie L Williams
Krystyna Mozdzanowska
Loren D Erickson
Michael P Cancro
Michele Metzgar
P2860
P304
P356
10.1172/JCI57362
P407
P577
2011-09-01T00:00:00Z